Glatiramer Acetate

Top drugs and pharmaceutical companies of 2019 by revenues

Acquisitions and spin-offs dominated headlines in 2019 and the tone was set very early with Bristol-

Dead fish in Hyderabad puts pharma majors under scrutiny; False data uncovered in AstraZeneca’s US$ 4 billion buy

This week, Phispers has news from across the world. While China is trying to speed up approval of dr

FDA to share full inspection reports with EU; Difficult week for Teva, J&J, Mylan

This week, Phispers brings you the latest from the world of biosimilars, with Samsung Bioepis tying

Dr. Reddy’s fails EU inspection; Trump disbands business councils after Merck CEO and others quit it over intolerance

This week, Phispers brings you the high-pitched drama from President Trump’s American Manufact

GSK’s overhaul begins under new CEO; Sandoz loses US$ 940 million lawsuit

This week, Phispers brings you news on GSK, whose new CEO is planning a slew of initiatives to make

FDA problems at Pfizer’s US facility continue; China FDA joins ICH

This week in our compliance round up, we look at the continuing problems at Pfizer’s McPherson

Does the FDA promote European manufacturers over others? The ice-bucket challenge winner!

This week, Phispers brings you a short analysis on how FDA might be promoting European drugmakers ov

Pfizer’s US facility receives a warning letter, as Baxter’s cGMP deficiencies result in multi-million dollar legal settlement

Within two months of 2017, we have already seen several pharmaceutical companies come under the regu

Teva CEO steps down; FDA Warning Letters to firms in Japan, India & China

This week, Phispers highlights more bad news for Israeli drugmaker Teva, along with news on the &lsq

China shuts plants of major antibiotic producers to fight pollution; more troubles for Teva

This week, Phispers has lots on generics. While the global leader Teva has more troubles at hand, ge